Our study revealed a novel link between the levels of IL‐33 and OPN in the peripheral blood and tumor growth, thus suggesting that the two cytokines could be considered as simple and efficient biomarkers to evaluate the effectiveness of early cetuximab treatment of CRC (Figure 6H). This evidence concerns the gene IL33 and neoplasm.